𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trials for early (pre-dementia) Alzheimer’s disease: A case for mild cognitive impairment

✍ Scribed by R. C. Petersen

Publisher
Springer
Year
2010
Tongue
English
Weight
42 KB
Volume
14
Category
Article
ISSN
1279-7707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracranial volume in mild cognitive im
Intracranial volume in mild cognitive impairment, Alzheimer's disease and vascular dementia: evidence for brain reserve?
✍ Henrike Wolf; Per Julin; Hermann-Josef Gertz; Bengt Winblad; Lars-Olof Wahlund 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract ## Objective The possibility of brain volume reserve effects was examined in a sample of geriatric outpatients with mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular dementia (VaD). The total intracranial volume (ICV) served as an estimate of the maximum attained b

Screening for amnestic mild cognitive im
Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population
✍ L. Rami; J. L. Molinuevo; R. Sanchez-Valle; B. Bosch; A. Villar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Objectives To design and validate a new screening test for amnestic Mild Cognitive Impairment (A‐MCI) and early stage Alzheimer's disease (AD). ## Methods We develop a verbal episodic and semantic memory test: the Memory Alteration Test (M@T). Discriminative validity was assessed

Memory complaints and increased rates of
Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease
✍ H. A. Archer; J. Kennedy; J. Barnes; T. Pepple; R. Boyes; K. Randlesome; S. Cleg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract ## Aim To determine rates of cerebral atrophy in individuals with symptoms of memory loss but no objective cognitive impairment (SNCI) and their association with future cognitive decline. ## Methods Thirty‐two SNCI subjects, 16 with mild cognitive impairment (MCI) and 27 control subj